Co‐based Nanozymatic Profiling: Advances Spanning Chemistry, Biomedical, and Environmental Sciences

J Li, X Cai, P Jiang, H Wang, S Zhang, T Sun… - Advanced …, 2024 - Wiley Online Library
Nanozymes, next‐generation enzyme‐mimicking nanomaterials, have entered an era of
rational design; among them, Co‐based nanozymes have emerged as captivating players …

The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease

JC Hogg, PD Paré, TL Hackett - Physiological reviews, 2017 - journals.physiology.org
The hypothesis that the small conducting airways were the major site of obstruction to airflow
in normal lungs was introduced by Rohrer in 1915 and prevailed until Weibel introduced a …

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

KF Rabe, S Hurd, A Anzueto, PJ Barnes… - American journal of …, 2007 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is
the fourth leading cause of chronic morbidity and mortality in the United States, and is …

Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations

A Papi, CM Bellettato, F Braccioni… - American journal of …, 2006 - atsjournals.org
Rationale: Severe exacerbations of chronic obstructive pulmonary disease (COPD) are
major causes of health care costs mostly related to hospitalization. The role of infections in …

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

S Sethi, N Evans, BJB Grant… - New England Journal of …, 2002 - Mass Medical Soc
Background The role of bacterial pathogens in acute exacerbations of chronic obstructive
pulmonary disease is controversial. In older studies, the rates of isolation of bacterial …

COPD exacerbations: definitions and classifications

S Burge, JA Wedzicha - European Respiratory Journal, 2003 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is defined independently of exacerbations,
which are largely a feature of moderate-to-severe disease. This article is the result of a …

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

JA Wedzicha, PMA Calverley… - American journal of …, 2008 - atsjournals.org
Rationale: Exacerbations are key drivers of morbidity and mortality in chronic obstructive
pulmonary disease (COPD). Objectives: We compared the relative efficacy of the long-acting …

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

IS Patel, TAR Seemungal, M Wilks, SJ Lloyd-Owen… - Thorax, 2002 - thorax.bmj.com
Background: Patients with chronic obstructive pulmonary disease (COPD) are prone to
frequent exacerbations which are a significant cause of morbidity and mortality. Stable …

Impact of exacerbations on COPD

A Anzueto - European Respiratory Review, 2010 - Eur Respiratory Soc
Exacerbations of chronic obstructive pulmonary disease (COPD) determine disease-
associated morbidity, mortality, resource burden and healthcare costs. Acute exacerbation …

Exacerbations of chronic obstructive pulmonary disease

BR Celli, PJ Barnes - European Respiratory Journal, 2007 - Eur Respiratory Soc
Exacerbations of chronic obstructive pulmonary disease are of major importance in terms of
their prolonged detrimental effects on patients, the acceleration in disease progression and …